CD47 and neoplasm: For example, there is evidence that the suppression of CD47/SIRPα signaling pathway components leads to the activation of tumor cell phagocytosis by macrophages [123], and high CD47 expression correlates with low PFS (progression-free survival) and OS (overall survival) rates [124].